Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$5.04B |
| 2 |
NVIDIA
NVDA
|
+$2.69B |
| 3 |
Broadcom
AVGO
|
+$2.06B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.46B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.36B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$667M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$649M |
| 3 |
TSMC
TSM
|
+$483M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$473M |
| 5 |
Walmart Inc
WMT
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 9.61% |
| 3 | Consumer Discretionary | 7.75% |
| 4 | Healthcare | 6.29% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEUS
3276
DELISTED
Olympic Steel
ZEUS
| $5.69M | ﹤0.01% |
174,595
+32,045
| +22% | +$1,000K |
|
|
GRFS
3277
Grifois
GRFS
$5.4B
| $5.68M | ﹤0.01% |
628,673
-3,583,359
| -85% | -$28M |
|
3278
EPR Properties
EPR
$4.68B
| $5.67M | ﹤0.01% |
97,400
+1,339
| +1% | +$70.5K |
|
3279
OneSpan
OSPN
$604M
| $5.67M | ﹤0.01% |
339,817
-50,282
| -13% | -$780K |
|
|
ANSC
3280
Agriculture & Natural Solutions Acquisition Corp
ANSC
$476M
| $5.65M | ﹤0.01% |
521,183
| – | – |
|
3281
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$233M
| $5.64M | ﹤0.01% |
60,109
-7,924
| -12% | -$1.05M |
|
3282
Xencor
XNCR
$1.47B
| $5.63M | ﹤0.01% |
716,392
-10,342
| -1% | -$92.8K |
|
3283
City Holding Co
CHCO
$2.06B
| $5.63M | ﹤0.01% |
45,960
-40,016
| -47% | -$4.7M |
|
|
AMTM
3284
Amentum Holdings
AMTM
$5.72B
| $5.63M | ﹤0.01% |
238,247
-209,331
| -47% | -$4.37M |
|
3285
iShares California Muni Bond ETF
CMF
$4.61B
| $5.62M | ﹤0.01% |
100,882
+94,664
| +1,522% | +$5.26M |
|
3286
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$581M
| $5.62M | ﹤0.01% |
137,028
-18,395
| -12% | -$729K |
|
3287
Ocular Therapeutix
OCUL
$1.87B
| $5.62M | ﹤0.01% |
605,165
+23,156
| +4% | +$181K |
|
3288
CALL
Intercontinental Exchange
ICE
$84.1B
| $5.61M | ﹤0.01% |
30,600
+5,300
| +21% | +$911K |
|
3289
Symbotic
SYM
$5.92B
| $5.61M | ﹤0.01% |
144,402
-74,030
| -34% | -$1.94M |
|
|
MRLN
3290
Merlin Inc
MRLN
$401M
| $5.61M | ﹤0.01% |
543,963
| – | – |
|
|
MRUS
3291
DELISTED
Merus
MRUS
| $5.61M | ﹤0.01% |
106,618
-18,177
| -15% | -$855K |
|
|
GOOS
3292
Canada Goose Holdings
GOOS
$861M
| $5.6M | ﹤0.01% |
500,036
+190,801
| +62% | +$1.85M |
|
3293
Castle Biosciences
CSTL
$929M
| $5.58M | ﹤0.01% |
273,443
+98,118
| +56% | +$1.82M |
|
3294
Immatics
IMTX
$1.34B
| $5.57M | ﹤0.01% |
1,034,825
-952,467
| -48% | -$4.72M |
|
3295
PUT
Elevance Health
ELV
$84.8B
| $5.56M | ﹤0.01% |
14,300
-2,100
| -13% | -$845K |
|
3296
CALL
TJX Companies
TJX
$177B
| $5.56M | ﹤0.01% |
45,000
| – | – |
|
|
3297
PUT
TJX Companies
TJX
$177B
| $5.56M | ﹤0.01% |
45,000
| – | – |
|
3298
Red Violet
RDVT
$963M
| $5.55M | ﹤0.01% |
112,761
-18,739
| -14% | -$818K |
|
3299
CALL
BioNTech
BNTX
$23.3B
| $5.55M | ﹤0.01% |
52,100
| – | – |
|
|
OACC
3300
Oaktree Acquisition Corp III Life Sciences
OACC
$264M
| $5.53M | ﹤0.01% |
529,535
| – | – |
|
Similar funds
Goldman Sachs's Q2 2025 Portfolio in Review
As of Q2 2025, Goldman Sachs held 6,593 positions worth $736B, up 19% from $618B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Goldman Sachs deployed $48.5B of net new capital in Q2 2025, opening 562 new positions and adding to 2,527 existing holdings. Its largest new stake was Emera Inc: 5,401,728 shares worth $248M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $667M trimmed.
- Goldman Sachs's largest Q2 2025 buy was Emera Inc: 5,401,728 shares worth $248M.
- Goldman Sachs added most to Tesla in Q2 2025, an estimated $5.04B increase.
- Goldman Sachs's biggest Q2 2025 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $667M.
- Goldman Sachs fully exited Discover Financial Services in Q2 2025, selling an estimated $296M.
- Goldman Sachs's ten largest holdings make up 21% of its $736B portfolio in Q2 2025.
- Goldman Sachs opened 562 new positions and closed 544 in Q2 2025.
- Goldman Sachs's portfolio value rose 19% quarter-over-quarter to $736B.
Based on Goldman Sachs's 13F filing for Q2 2025, filed 14 Aug 2025.